Filing Details
- Accession Number:
- 0001209191-21-045204
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-07-02 20:50:08
- Reporting Period:
- 2021-06-30
- Accepted Time:
- 2021-07-02 20:50:08
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1651944 | Dermtech Inc. | DMTK | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1221822 | R Scott Pancoast | C/O Dermtech, Inc. 11099 N. Torrey Pines Rd. Suite 100 La Jolla CA 92037 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2021-06-30 | 4,606 | $42.32 | 48,684 | No | 4 | S | Direct | |
Common Stock | Disposition | 2021-06-30 | 394 | $43.50 | 48,290 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2021-07-01 | 2,406 | $0.00 | 50,696 | No | 4 | A | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | A | Direct |
Footnotes
- The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 26, 2021.
- This transaction was executed in multiple trades at prices ranging from $42.08 to $42.85, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- The securities awarded are in the form of restricted stock units issued pursuant to the issuer's 2020 Equity Incentive Plan. Each restricted stockunit represents a right to receive one share of issuer common stock. The award will vest in full and be released at the next annual meeting of stockholders of the Company.